Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Certified Bariatric Surgeons Change People’s Lives

Leave a comment


Dr. Huacuz has earned an international reputation for his expertise in Gastric Sleeve and Gastric Bypass procedures.

TIJUANA, Mexico, Dec. 6, 2023 /PRNewswire-PRWeb/ — Are you tired of struggling with your weight? Do you feel like you have tried everything and nothing works? It’s time to consider bariatric surgery with Dr. Daniel Huacuz Guízar, MD, one of the best certified bariatric surgeons in Tijuana.

Dr. Huacuz has earned an international reputation for his expertise in Gastric Sleeve and Gastric Bypass procedures.

With over 20 years of experience in bariatric surgery, Dr. Huacuz has earned an international reputation for his expertise in Gastric Sleeve and Gastric Bypass procedures.

Thousands of people from the USA, Canada, and other countries have chosen to undergo weight loss surgery in Tijuana, Mexico with Dr. Huacuz Guízar.

“Dr. Huacuz performed a vertical sleeve gastrectomy on me last October, and since then, I have lost 125 pounds, and it’s been a little less than a year. It was the best decision that I’ve ever made in my life,” said an American patient from Certified Bariatric Surgeons.

Dr. Huacuz Guízar and his team of dedicated Board Certified Bariatric Surgeons provide a comfortable environment before, during, and after surgery. They take the time to listen carefully to their patients and consider the most convenient option between gastric sleeve vs. gastric bypass, or any other bariatric surgery that you and the surgical team choose as the best for you.

Furthermore, Dr. Huacuz Guízar’s location in Tijuana also allows him to provide care for a reasonable price. Patients spend just a few nights in a five star hotel to keep monitoring their healing and progress before they return home.

If you’re ready to make a change in your life and achieve your weight loss goals, choose Dr. Faustino Daniel Huacuz Guízar, MD and his team of certified bariatric surgeons. Contact us today to schedule your consultation and take the first step towards a healthier and happier you.

Media Contact

Dr. Faustino Daniel Huacuz Guízar, https://certifiedbariatricsurgeons.com/, 1 (619) 270 53 88, [email protected], https://certifiedbariatricsurgeons.com/

SOURCE Certified Bariatric Surgeons

Health

OOVA Launches Perimenopause Hormone Kit, First-of-its-Kind Estrogen Biomarker and App with Real-Time Data Tracking

Leave a comment


The women’s health platform is the only remote hormone monitoring company trusted and used by physicians

NEW YORK, Dec. 6, 2023 /PRNewswire-PRWeb/ — Oova, Inc., the leading women’s health platform revolutionizing remote hormone monitoring, announced today the launch of its at-home Perimenopause Hormone Kit. The kit is complete with urine-based, multi-hormone biomarkers including estrogen (E3G) and an app with real-time data tracking. Unlike other options on the market, which rely on blood or FSH-only urine tests that only capture a moment in time, Oova users are able to measure their actual hormone fluctuations across a 15-day period throughout a single cycle and their progress month-over-month. This gives women and their physicians insights into their perimenopause journey.

The test strips are scanned into Oova’s HIPPA-compliant app which utilizes advanced AI and machine learning to interpret the scan into quantitative results, which can be understood by patients and clinicians alike. By interpreting the quantitative levels over time, Oova’s predictive algorithms begin to learn the nuances of every woman’s unique hormone profile to help her achieve her health goal. Insights include measuring perimenopausal hormone activity, tracking unique physical symptoms, indicating fertility and confirming ovulation for those trying to conceive during perimenopause. It also enables monitoring of hormone patterns for those beginning Hormone Replacement Therapy (HRT). Patients can also share their data with clinicians in real-time, from the comfort of home.

“There are significant gaps in hormone health research, especially as it relates to perimenopause,” said Amy Divaraniya, Ph.D., Founder and CEO of OOVA. “We know doctors and patients alike are missing methods to pinpoint where someone is in their journey and identify how symptoms correspond to hormone changes, which often leaves women navigating this life phase in the dark. With the Perimenopause Hormone Kit, women can better understand their bodies, while tracking data that empowers them to make informed decisions with their physicians.”

“Oova’s test serves as a significant leap forward in healthcare,” said Dr. Beck Hoehn, LAc, FABORM, Mighty River Wellness, Advisor to Oova. “In this stage of women’s health that has traditionally been passed over, Oova’s perimenopause kit equips both the patient and clinician with real-time, accurate insight needed to navigate the complexities with confidence and clarity. It’s a game-changer.”

Oova stands out as the only remote hormone monitoring company working directly with clinicians, and conducting medical studies to support its claims. Founded by Amy Divaraniya, Ph.D., an expert in biomedical sciences with a focus on genetics, the company began with ovulation tracking for fertility. With a recent $10.3M fundraise, Oova is continuing to expand its scope to support women through every stage, age and life phase, from their first period to their last and beyond.

The launch of the E3G biomarker expands upon Oova’s current physician-preferred fertility monitoring offering of luteinizing hormone (LH) and progesterone (PdG) biomarkers to complete the Perimenopause Hormone Kit. The Perimenopause Hormone Kit ($159.99), retailing online and in store at Village Pharmacy, includes 15 E3G tests and 15 LH/PdG hormone tests , designed to be used over the course of a month for a detailed and comprehensive picture of hormone behavior. Also available is The Oova Perimenopause Membership Kit ($129.99/month) for an ongoing test strip subscription with full-circle support from Oova’s hormone specialists and access to the Oova community.

To learn more about Oova and its perimenopause offering, visit oova.life.

About Oova, Inc.
Oova, the women’s health platform revolutionizing remote hormone monitoring, fully illuminates women’s fertility and perimenopause journeys, giving them and their care team the clearest steps forward. Founded by doctors and backed by Mount Sinai Hospital, Oova has created a consumer-first, data-driven experience valuable to patients and healthcare providers. Oova’s at-home kits measure luteinizing hormone, progesterone, and estrogen for fertility, to immediately inform a woman of her most fertile days and confirm ovulation, and for perimenopause to provide clarity on symptoms and changes. By delivering advanced personalized analytics and real-time action plans with every hormone reading, Oova is transforming the fertility and perimenopause care experience. Learn more at oova.life. 

Media Contact

Kari Porter, Oova, 913-488-2794, [email protected], https://www.oova.life

SOURCE Oova

Health

Unraveling the Essentials of Healthcare Regulatory Compliance in Florida

Leave a comment


In the ever-evolving landscape of healthcare, regulatory compliance stands as a cornerstone for ensuring the delivery of safe, effective, and high-quality patient care. Understanding the intricacies of compliance in healthcare, particularly in states like Florida, is essential for healthcare providers and organizations. In this blog, we’ll delve into the concept of regulatory compliance in healthcare, with a specific focus on its significance in Florida and the role of regulatory compliance services in ensuring adherence to state-specific standards.

MIAMI, Dec. 6, 2023 /PRNewswire-PRWeb/ — In the ever-evolving landscape of healthcare, regulatory compliance stands as a cornerstone for ensuring the delivery of safe, effective, and high-quality patient care. Understanding the intricacies of compliance in healthcare, particularly in states like Florida, is essential for healthcare providers and organizations. In this blog, we’ll delve into the concept of regulatory compliance in healthcare, with a specific focus on its significance in Florida and the role of regulatory compliance services in ensuring adherence to state-specific standards.

Defining Compliance in Healthcare:

Compliance in healthcare refers to the process of adhering to laws, regulations, guidelines, and standards set by government bodies and other authoritative organizations. It encompasses a wide range of areas, including patient care, privacy, billing, and the overall operations of healthcare entities. The primary goal of healthcare regulatory compliance is to safeguard patients, maintain the integrity of healthcare services, and uphold ethical standards within the industry.

The Regulatory Landscape in Healthcare:

The healthcare sector operates within a complex web of federal, state, and local regulations. In Florida, regulatory compliance is particularly crucial, given the state’s commitment to ensuring the highest standards of healthcare delivery. From licensing requirements for healthcare professionals to specific regulations governing healthcare facilities, Florida has a comprehensive framework in place to oversee and regulate the healthcare industry.

Healthcare Regulatory Compliance in Florida:

Florida’s healthcare regulatory landscape is multifaceted, covering a spectrum of areas that impact both individual practitioners and healthcare organizations. Key aspects of healthcare regulatory compliance in Florida include licensure requirements, patient privacy laws (such as the Health Insurance Portability and Accountability Act or HIPAA), billing and coding regulations, and standards for the quality of care provided.

Regulatory Compliance Services in Florida:

Navigating the intricate web of healthcare regulations in Florida can be a daunting task for healthcare providers. Regulatory compliance services play a pivotal role in assisting healthcare organizations in meeting and maintaining compliance standards. These services often include thorough assessments of current practices, development of customized compliance programs, staff training, and ongoing monitoring to ensure continuous adherence to regulatory requirements.

The Significance of Regulatory Compliance in Florida:

Ensuring compliance with healthcare regulations in Florida is not merely a matter of avoiding legal repercussions; it is about safeguarding the well-being of patients and upholding the integrity of the healthcare system. Non-compliance can result in legal consequences, financial penalties, damage to reputation, and, most importantly, compromised patient care. By prioritizing regulatory compliance, healthcare providers contribute to building trust among patients, fostering a culture of ethical practice, and ultimately enhancing the overall quality of healthcare services in the state.

Healthcare regulatory compliance is an ever-present responsibility for healthcare providers and organizations, particularly in a state like Florida with robust regulatory frameworks. Embracing the principles of compliance not only ensures legal adherence but also elevates the standard of patient care. Regulatory compliance services in Florida serve as invaluable partners in this journey, providing guidance and support to navigate the complex regulatory landscape and ultimately contribute to a healthcare environment that prioritizes safety, transparency, and excellence.

Media Contact

Florida Healthcare Law Firm, Florida Healthcare Law Firm, (561) 455-7700, [email protected], https://floridahealthcarelawfirm.com/

SOURCE Florida Healthcare Law Firm

Lifestyle: Self Help

Ronald A. Murphy DMD Supports Battles Against Poverty and Illiteracy

Leave a comment


“The Christmas Wish started as the Kid’s Crusade Foundation for the purpose of assisting children in need and children’s charities. In 1973, the name was changed to the CHUM Charitable Foundation in order to broaden the scope of the foundation’s work, including the increase in requests for financial assistance.”

Dr. Ron Murphy, has been supporting youth organizations by giving great reading materials that inspire and uplift. He has provided well over 75,000 books to these groups in the past few years. Toys for Tots, Boys & Girls Clubs, and schools and libraries through the US have sent praise and appreciation for his unrelenting dedication and support.

He’s decided that there is yet another place that he can bring his help and he is doing just that.

Dr. Murphy recently said, “When I realized that the purpose of the Christmas Wish is really: ‘Give joy today, restore hope for tomorrow.’ I knew I had to support them. This aligns with my very purpose which is to give joy and restore hope to our youth through books. Books are inspirational and bring hope. Good characters set good examples, they work for the good and overcome obstacles. The youth impacted by the Christmas Wish deserve to have hope. And so I must work to make sure they do!”

Dr. Murphy continues to give to his community and beyond and is a leader not only as a health care and professional but also as a friend to the world at large.

BIO:

Dr. Murphy graduated from SIU Dental School in Alton, IL in 2002. He did his undergraduate at Bradley University graduating in 1998.

His practice is located in Batavia, IL where he has been practicing since January of 2005. He resides in Batavia with his wife and three young girls. During dental school, Dr. Murphy went to Jamaica on a humanitarian trip where the team of doctors and students performed extractions, cleanings and basic restorative procedures. Furthermore, when he graduated from SUI Dental School, he received an award from The Academy of Operative Dentistry.

He is currently a member of American Dental Association, Illinois Dental Society (http://www.isds.org), Fox Valley Dental Society, Chicago Dental Society, and the Academy of General Dentistry. He has received an award for Top Doc organization in 2011.

Dr. Murphy enjoys spending time within the community. He has been a member of Batavia Rotary since 2005 and severed as Secretary of the club for 2 years. Furthermore, he is member of Batavia Chamber of Commerce and served on Batavia Access Fireworks Committee.

Dr. Murphy likes to spend his free time traveling to warm places. Furthermore, he enjoys deep sea fishing. He is still looking for the blue marlin that got away from him on his honeymoon in 2002. He enjoys spending time with his family. The three girls keep him hopping.

To this day, he still gets tremendous satisfaction with every patient he is able to help. A smile brings happiness and he is proud to be a provider that can help spread health and happiness to the world.

Contact for more information:
Ronald A. Murphy, DMD
General & Cosmetic Dentistry
1605 W Wilson Street #114
Batavia, IL 60510
(630) 793-0729
[email protected]
[email protected]
https://www.murphydentistry.com/

SOURCE Ronald A. Murphy DMD

Health: Abortion

Federal Enforcement Homeland Security Foundation Announces New CEO

Leave a comment


“The mission of my life changed that day,” said Montanaro. “Amid the tragedy, it meant the world to know that FEHSF didn’t just show up, they truly cared about my family. The organization showcases the best in humanity; leading it isn’t work for me, it’s a labor of love.”

FEHSF’s role as the ‘Financial First Responder’ extends to the families of Federal Agents and Officers from agencies including the ATF, CBP, DEA, FBI, IRS, and Secret Service. FESHSF has disbursed hundreds of financial grants over the organization’s more than 20-year history, with total assistance exceeding $4 million.

“William embodies the reason we exist: to be a light in the darkness for families enduring unimaginable pain, and to support those who sacrifice every day to keep our nation safe,” said FEHSF Honorary Chairman Tom Ridge, who served as a Congressman, Governor of Pennsylvania, and the inaugural Secretary of The Department of Homeland Security. “He is uniquely positioned to ensure that we have their backs, just as they have ours.”

In 2024, FEHSF aims to increase its grants for line-of-duty deaths to $25,000 per family, as well as to establish a scholarship fund for the children of fallen Agents and Officers. For more information and to donate, please visit https://www.fehsf.org/.

About FEHSF
The Federal Enforcement Homeland Security Foundation is a non-profit humanitarian, apolitical and patriotic 501(c)(3) corporation, formed as a private/public partnership of concerned business leaders and former and current high-ranking Federal Law Enforcement officials. FEHSF’s mission is to provide emergency funding to the Federal Law Enforcement Community within 24-48 hours of notification. FEHSF provides financial support to families of Agents and Officers who are seriously injured or killed in the line of duty protecting the nation’s citizens or enforcing our laws. Additionally, FEHSF supports those Agents or Agents’ families during times of personal difficulties, tragedies, or financial hardship.

Media Contact

Ariel Grossman, The Federal Enforcement Homeland Security Foundation, 561-703-4278, [email protected], https://www.fehsf.org/

SOURCE The Federal Enforcement Homeland Security Foundation

Health: Abortion

Gilbane Building Company Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index (CEI)

Leave a comment


The results of the 2023-2024 CEI showcase how companies are promoting LGBTQ+-friendly workplace policies. The first year of the CEI included 319 participants, and the 2023-2024 CEI now includes 1,384 participants, further demonstrating the tremendous trajectory of the CEI. A record-breaking 1,340 businesses have non-discrimination protections specific to gender identity, up from just 17 in 2002. These critical non-discrimination protections cover 21 million employees in the U.S. and around the globe. Gilbane’s efforts in satisfying all the CEI’s criteria earned a score of 100 and the designation as recipient of the Equality 100 Award: Leader in LGBTQ+ Workplace Inclusion.

“Gilbane has a robust employee resource group (ERG) program and we’re proud of their work to support an inclusive culture,” said Kavon Archie, Senior Inclusion Manager, Gilbane Building Company. “Our PRIDE ERG is a trusted resource supporting LGBTQIA causes and matters both within Gilbane and throughout the industry. We applaud PRIDE and all of our ERGs for their commitment to enhancing career and personal development and making a difference in building a sense of belonging across our organization.”

The CEI rates companies on detailed criteria falling under four central pillars:

  • Non-discrimination policies across business entities
  • Equitable benefits for LGBTQ+ workers and their families
  • Supporting an inclusive culture
  • Corporate social responsibility

“For well over two decades, businesses have played an important role in furthering LGBTQ+ equality by centering employee needs and voices when it comes to workplace inclusion. While there is much more work to be done, year-over-year growth in CEI participation is evidence of a business community that recognizes the responsibility and value in upholding equity and inclusion,” said RaShawn “Shawnie” Hawkins, Human Rights Campaign Sr Director of Workplace Equality. “Our goal at the Human Rights Campaign Foundation is to work in a spirit of partnership with companies, providing educational resources and leading benchmarking, and collaborating on ways for businesses to support the LGBTQ+ community at a time when we face unprecedented legislative attacks, heightened anti-LGBTQ+ rhetoric and physical violence. The CEI is an ever-evolving tool – a blueprint that companies can use to show up more effectively in supporting their LGBTQ+ employees and their families.”

The full report is available online at http://www.hrc.org/cei.

About the Human Rights Campaign Foundation:
The Human Rights Campaign Foundation is the educational arm of the Human Rights Campaign (HRC), America’s largest civil rights organization working to achieve equality for lesbian, gay, bisexual, transgender and queer (LGBTQ+) people. Through its programs, the HRC Foundation seeks to make transformational change in the everyday lives of LGBTQ+ people, shedding light on inequity and deepening the public’s understanding of LGBTQ+ issues, with a clear focus on advancing transgender and racial justice. Its work has transformed the landscape for more than 15 million workers, 11 million students, 1 million clients in the adoption and foster care system and so much more. The HRC Foundation provides direct consultation and technical assistance to institutions and communities, driving the advancement of inclusive policies and practices; it builds the capacity of future leaders and allies through fellowship and training programs; and, with the firm belief that we are stronger working together, it forges partnerships with advocates in the U.S. and around the globe to increase our impact and shape the future of our work.

About Gilbane Building Company:
Gilbane Building Company is a global leader in construction management, delivering high-quality projects for clients across various markets. Gilbane provides a full slate of construction and facilities-related services – from preconstruction planning and integrated consulting capabilities to comprehensive construction management, general contracting, design-build, and facility management services. Founded in 1870, Gilbane is still a privately held, family-owned company. With more than 45 office locations worldwide, Gilbane brings world-class experience to local communities.

For more information, visit http://www.gilbaneco.com.

Media Contact

Lynn Rasic, Gilbane Building Company, 212-822-0319, [email protected], gilbaneco.com

SOURCE Gilbane Building Company

Health

Breast International Group (BIG) Highlights Innovations and Challenges in Breast Cancer Research, Exclusive Interview by Xtalks

Leave a comment


In an interview by Xtalks, Dr. David Cameron, Chair of the Breast International Group (BIG), shared valuable insights into the current state of breast cancer research, emphasizing the role of clinical trials and the integration of patient perspectives in research. BIG’s efforts, as outlined by Dr. Cameron, represent a substantial leap forward in understanding and treating breast cancer, with a strong emphasis on global collaboration and patient involvement.

TORONTO, Dec. 5, 2023 /PRNewswire-PRWeb/ — In an exclusive interview, Xtalks delves into the current state of breast cancer research, highlighting the role of clinical trials and the integration of patient perspectives in clinical research. Featuring Dr. David Cameron, Chair of the Breast International Group (BIG), the discussion revolves around the importance of collaboration and patient involvement in breast cancer clinical research.

Dr. Cameron emphasized the importance of international collaboration in advancing breast cancer research. BIG, as the leading global network of academic breast clinical trialists, is spearheading international efforts to innovate treatment options and
understand the complexities of breast cancer.

In the interview, Dr. Cameron highlighted the diverse nature of breast cancer and the resulting complexities in patient enrollment for clinical trials. Challenges include varying availability of trials, changing treatment philosophies, the complexity of the disease and the influence of public perception.

BIG has long valued the patient perspective, including them in trial steering groups. Dr. Cameron advocates for a more profound inclusion, where patients influence not just how trials are conducted but also which trials are pursued. This approach ensures that research aligns with patient priorities and questions.

Recognizing the global strides in involving patients in research, BIG is committed to a patient-centric approach. This includes international collaboration to shape trial questions and providing mentorship and training for patients to engage effectively in the research process.

BIG’s efforts, as outlined by Dr. Cameron, represent a significant leap forward in understanding and treating breast cancer, with a strong emphasis on global collaboration and patient involvement.

To read the full interview, visit Amplifying Patient Voices in Breast Cancer Clinical Trials.

ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Health

FHU Physical Therapist Assistant Program Receives Accreditation Status, Set to Graduate Inaugural Cohort

Leave a comment


The inaugural cohort of the PTA program began courses in the fall of 2022 and will graduate on December 15, 2023. Students will sit for their national licensure examination (NPTE) in the spring of 2024. The program currently has two cohorts of students.

Applications for the fall 2024 cohort will open on December 1, 2023, with a deadline for submission on March 31, 2024. The PTA program accepts a maximum of 18 students each fall semester. The program is a 1+1 degree model, meaning that students who have already completed prerequisite and general education requirements can complete the program in as few as three academic semesters. Students without any academic credit will need five semesters.

Classes are taught four days per week during the fall and spring semesters. The program is a three-semester blend of didactic and clinical education experiences. It includes 640 hours of clinical experience in both the outpatient and inpatient settings under the supervision of a licensed physical therapist or a physical therapist assistant who is supervised by a licensed physical therapist. At this time, students have completed clinical education rotations in Tennessee, Mississippi, Alabama, Colorado and Wyoming. In addition to clinical education experiences, the program has created a voluntary medical missions experience to Honduras that takes place each summer.

Prentice serves as the PTA program director. A 2012 alumna of FHU, she has been a practicing clinician since 2015. Brian Vaughn, with more than 20 years of experience in the outpatient clinical setting, serves as the program’s director of clinical education. Both faculty members hold a Master of Education in curriculum and instruction from Freed-Hardeman University.

CAPTE is the only accreditation agency recognized by the United States Department of Education and the Council for Higher Education Accreditation to accredit entry-level physical therapist and physical therapist education programs, according to its website. The organization currently accredits more than 250 physical therapist education programs and more than 350 physical therapy assistant programs, predominantly in the United States.

The Physical Therapist Assistant Program at Freed-Hardeman University is accredited by the Commission on Accreditation in Physical Therapy Education (CAPTE), 3030 Potomac Ave., Suite 100, Alexandria, Virginia 22305-3085; telephone: 703-706-3245; email: [email protected]; website: capteonline.org. In order to contact the program/institution directly, please call 731-989-6097 or email [email protected].

The mission of Freed-Hardeman University’s Physical Therapist Assistant Program is to equip students with an education that integrates Christian faith, scholarship and service in order to provide holistic healthcare services to individuals and communities throughout the world. By growing in knowledge through dedicated faculty and a comprehensive curriculum focused on contemporary practice, the program will prepare graduates to serve as competent and ethical physical therapist assistants working under the direction and supervision of a licensed physical therapist.

Media Contact

Dawn Bramblett, Freed-Hardeman University, 731-608-7650, [email protected], fhu.edu

SOURCE Freed-Hardeman University

Health: Mental Health

Convergent Dental reaches new milestone as its Solea® All-Tissue Dental Laser is now being used by dentists in all 50 U.S. states

Leave a comment


The Solea All-Tissue Laser is a comprehensive dental practice solution unlike any other. It’s a 9.3-µm CO2 laser that allows for anesthesia-free, blood-free, and pain-free procedures in hard and soft tissue.(1) Convergent Dental unites this novel technology with education & community, enabling dentists to elevate and grow their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.

“Solea elevates practice possibilities and serves as a practice multiplier, allowing dentists to streamline existing procedures, add new treatments, and complement their digital technology,” said Robert L. Gershon, CEO of Convergent Dental. “We are thrilled to see continued broad-based adoption of Solea throughout North America and beyond.”

To learn more about Convergent Dental, visit convergentdental.com.

About Convergent Dental
Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on.(1) Solea® is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.(2)

For more information, please visit http://www.convergentdental.com. Follow the company on Instagram, Facebook and LinkedIn.

[1] Based on report of 1000 procedures performed by Solea users. Documentation on file.
[2] Based on 2022 Annual Survey of Solea users. Documentation on file.

Media Contact

Caitlin D’Entremont, Convergent Dental, 508-500-5056, [email protected], https://www.convergentdental.com/

SOURCE Convergent Dental



Health

FreeOx Biotech Formally Launches Seed Round to Fund Phase III Pivotal Trial

Leave a comment


Planned Phase III for Ox-01 to Begin in AIS in Early 2025 • Pivotal Trial to Evaluate Novel Adjunct Drug for Mechanical Thrombectomy

BARCELONA, Spain, Dec. 5, 2023 /PRNewswire-PRWeb/ — FreeOx Biotech SL, a late-stage clinical biopharmaceutical company pioneering the development of a novel drug class for Acute Ischemic Stroke (AIS), announced today the formal launch of a seed round to advance the company’s novel stroke drug into Phase III clinical development. Simultaneously, FreeOx said it had successfully completed a first close of €1.7 million from investors in Canada, the U.S., Spain, and Israel. The company has compelling Phase II data and plans to initiate a Phase III registrational trial of its first novel adjunct drug to be used in mechanical thrombectomy (MT) in AIS where reperfusion challenges exist despite positive outcomes in this modality. FreeOx has strong intellectual property covering Uric Acid and its use in stroke treatment.

According to Chairman of the Board and Chief Executive Officer Emmett-Phil Coriat, “The endorsement of Uric Acid (UA), the active ingredient in Ox-01, our Phase III-ready investigational drug by the National Institutes of Health, NINDS’ SPAN (Stroke Preclinical Assessment Network), is central to our confidence in moving forward. As reported in SCIENCE TRANSLATIONAL MEDICINE, Uric Acid was the only one of five interventional drug candidates for which data supported further clinical evaluation, as it demonstrated unprecedented efficacy compared to the others. As such, the NINDS indicated potential interest in funding Ox-01’s Phase III trial.

“The NINDS’ advocacy underscores their confidence in the efficacy and potential of Ox-01 as a ground-breaking adjunct therapy in MT for AIS. We are confident that Ox-01 will significantly reduce disability in AIS patients.” Coriat added that that the company’s fundraising target was a total investment of €5 million and that the initial €1.7 million will be used primarily to advance FreeOx Biotech’s lead product, Ox-01 to a Phase III registrational trial in the U.S. In addition to the pharmaceutical grade Uric Acid active ingredient in Ox-01, FreeOx is building a pipeline based on a proprietary liposomal formulation technology that broadly expands opportunities in neurology.

Stroke Background

Stroke is the leading cause of disability worldwide, according to the American Stroke Association. While advances have been made with mechanical thrombectomy, significant unmet needs exist when 50 percent of Large Vessel Occlusion patients have insufficient restoration of their microcirculation and ensuing disabilities.

For more information about FreeOx Biotech and its groundbreaking stroke treatment technology, please visit the company’s website at https://freeoxbiotech.com/.

About FreeOx Biotech

FreeOx Biotech is a leading late-stage clinical-stage biopharmaceutical company dedicated to developing Cerebrovascular Protective Therapy, a new drug class for the emergency treatment of Acute Ischemic Stroke (AIS) patients. By focusing on restoring microcirculation homeostasis and enhancing penumbra reperfusion, FreeOx Biotech aims to revolutionize stroke care and improve patient outcomes. FreeOx’ s lead product, Ox-01, is Phase III- ready. FreeOx is building a pipeline based on a proprietary liposomal formulation technology that broadly expands opportunities in neurology. Founded by Dr. !ngel Chamorro, MD, a leading stroke neurologist and pioneer in the use of Uric Acid as an emergency treatment for AIS, FreeOx ‘s novel adjunct drug has been shown to reperfuse the brain microcirculation. By contrast, current emergency AIS treatments are effective only in addressing recanalization (macrocirculation restoration).

Media Contact

Emmett-Phil Coriat, FreeOx Biotech, 1 (514)792-1264, [email protected] 

Gabriella Perez-Silva, 1 (714) 875-6424, [email protected] 

SOURCE FreeOx Biotech